USA Health University Hospital Fanny Meisler Trauma Center named in honor of local family.
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.
Rebecca Borneman, a fourth-year medical student at the University of California San Francisco School of Medicine, has won three awards for research on an anti-cancer compound at the USA Health Mitchell Cancer Institute.
Two faculty members in the USA College of Medicine Department of Physiology and Cell Biology have been recognized as Expertscape “World Experts” on the topic of myocardial reperfusion injury.
Researchers at the Center for Healthy Communities at the University of South Alabama College of Medicine explored this topic and have published a report to answer two critical questions.
Located at the USA Health Mitchell Cancer Institute, the biobank provides complete histology services; collection, processing and storing of biospecimens; and DNA and RNA extraction for biospecimen quality control.
USA Health research demonstrating that a vaccine made from patients’ own tumors could extend the lives of women with late-stage ovarian cancer, particularly those without a BRCA gene mutation, has been published in the December 2020 issue of The Lancet Oncology.
MCI researchers are using their findings to better understand why some cancer treatment responses may be affected differently depending on the patient’s vitamin B3 dietary intake and how a cancerous tumor can grow and spread because of a patient’s metabolism.
The 13th annual GO Run will be held virtually Sept. 17-20 and is presented by the Catranis Family Charitable Foundation.
A recent discovery at the University of South Alabama College of Medicine shows there is a contributor in the body that helps fight viral infections.
Breakthrough technology is providing researchers at USA Health Mitchell Cancer Institute a more precise understanding of how cancer cells grow.
As the opioid crisis continues to impact communities across the world, a physician-scientist at USA Health has been named the principal investigator of an international phase II clinical trial to evaluate the safety of a drug for babies born with neonatal opioid withdrawal syndrome.
The Vigil vaccine is a genetically engineered vaccine made from cancer cells acquired from patients during surgery.
Research completed at the USA Health Mitchell Cancer Institute suggests that aggressive uterine cancer may respond better to immunotherapy than slower growing types.
